Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 445, 354-355 (25 January 2007) | doi:10.1038/445354a; Published online 24 January 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Faculty Positions
- University of Houston
- Houston United States
Post-doctoral Positions-Bioinformatics and Stem Cells
- Boston University School of Medicine
- Boston, Massachusetts, United States
Crunch time for multiple-gene tests
Top of page
Abstract
Sophisticated new genetic tests face an uncertain future — unless they can win clear-cut approval from regulators, insurers and, most importantly, doctors. Virginia Gewin reports.
For many of the women who will learn this year that they have early-stage breast cancer, chemotherapy won't do any good. And a sophisticated genetic test is already available that might help to predict who they are.
To read this story in full you will need to login or make a payment (see right).
